Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business
Piroschka van de Wouw

Nurse first in Netherlands to get COVID-19 vaccination

39-year-old nursing home worker Sanna Elkadiri receives the first Pfizer/BioNTech COVID-19 vaccine in the Netherlands, the last country in the European Union to start vaccinations against the coronavirus disease (COVID-19), in Veghel, Netherlands, January 6, 2021. REUTERS/Piroschka van de Wouw/Pool

A Dutch nurse on Wednesday became the first person in the Netherlands to receive a COVID-19 shot as the European Union's last vaccination programme for the new coronavirus began after a late start.

Sanna Elkadiri, a 39-year-old who cares for dementia patients at a care home in the south of the country, received a shot of the vaccine developed by Pfizer and BioNTech on live television.

39-year-old nursing home worker Sanna Elkadiri talks to the media after receiving the first Pfizer/BioNTech COVID-19 vaccine in the Netherlands, the last country in the European Union to start vaccinations against the coronavirus disease (COVID-19), as Netherland's Health Minister Hugo De Jonge takes a picture, in Veghel, Netherlands, January 6, 2021. REUTERS/Piroschka van de Wouw/Pool

"This is the beginning of the end of this crisis," said Health Minister Hugo de Jonge at a brief ceremony.

Elkadiri said she didn't hesitate after being offered the chance to get the shot, travelling to a converted distribution centre capable of conducting hundreds of vaccinations per week.

Public anger swelled over the weekend and opinion polls showed support for the government waning after it became apparent the Netherlands was last among major European countries to begin vaccinations.

The empty container of the first used Pfizer/BioNTech COVID-19 vaccine in the last EU country to start vaccinations against the coronavirus disease (COVID-19) is pictured in Veghel, Netherlands, January 6, 2021. REUTERS/Piroschka van de Wouw/Pool

In a debate in parliament on Tuesday, Prime Minister Mark Rutte defended the slow roll out.

"The main problem was that we got it sooner than we had expected," Rutte said, referring to regulatory approval for a vaccine. "It was a different vaccine (than we had expected)...making it impossible to be flexible."

The Dutch government thought the Oxford-AstraZeneca vaccine would be approved first, though Rutte did not explain why. Moderna's vaccine is expected to become the second COVID-19 vaccine endorsed by the European Medicines Agency (EMA) later on Wednesday.

39-year-old nursing home worker Sanna Elkadiri receives the first Pfizer/BioNTech COVID-19 vaccine in the Netherlands, the last country in the European Union to start vaccinations against the coronavirus disease (COVID-19), in Veghel, Netherlands, January 6, 2021. REUTERS/Piroschka van de Wouw/Pool

After a review, the Dutch government and National Institute for Health (RIVM) dropped plans to vaccinate elderly people in care homes first. The Pfizer-BioNTech vaccine will go initially to nursing home staff and healthcare workers. That list will expand as more vaccines become available.

Coronavirus infections in the Netherlands have remained high in recent weeks, despite a tough lockdown in which all schools and most stores remain closed.

(Reporting by Toby Sterling; Editing by Andrew Heavens and Alex Richardson)

Netherland's Health Minister Hugo De Jonge applauds as 39-year-old nursing home worker Sanna Elkadiri received the first Pfizer/BioNTech COVID-19 vaccine in the Netherlands, the last country in the European Union to start vaccinations against the coronavirus disease (COVID-19), in Veghel, Netherlands, January 6, 2021. REUTERS/Piroschka van de Wouw/Pool
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.